Search
for
Did you mean Small Molecule Inhibitor?
Sort by
Research 30 of 1000+
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Molecular Targeted Agents and Biologic Therapies for Non-small Cell Lung Cancer
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- Patient‐Level Adverse Event Patterns in a Single‐Institution Study of the Multi‐Kinase Inhibitor Sorafenib
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Transcriptome-guided development of a fibrosis-reversal compound reduces skin scarring and allows regeneration via mitochondrial uncoupling
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Adverse Hair Reactions to New Targeted Therapies for Cancer
- Management of Toxicities of Targeted Therapies
- Cutaneous drug reactions
- EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management
- Spotlight commentary: Navigating the cutaneous side effects of chemotherapy
- Reversing Gray Hair: Inspiring the Development of New Therapies Through Research on Hair Pigmentation and Repigmentation Progress
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- The JAK/STAT signaling pathway: from bench to clinic
- PRMT5 inhibition has a potent anti-tumor activity against adenoid cystic carcinoma of salivary glands
- Merkel cell carcinoma: updates in tumor biology, emerging therapies, and preclinical models
- Alopecia in patients treated with molecularly targeted anticancer therapies
- Index
- Anagen effluvium
- Exploring the Role of Tripeptides in Wound Healing and Skin Regeneration: A Comprehensive Review
- Hair Changes due to Drugs
- Pre-clinical non-viral vectors exploited for<i>in vivo</i>CRISPR/Cas9 gene editing: an overview
- Drug eruptions in dermatology
- Corrective and Restorative Dermatology in Cancer Survivors: An Urgent Unmet Need!
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Therapies and nanotherapies for cervical cancer (Review)
- Combinatorial Therapy of Letrozole- and Quercetin-Loaded Spanlastics for Enhanced Cytotoxicity against MCF-7 Breast Cancer Cells